A Study of Gastroparesis Therapy Effectiveness

Overview

About this study

The purpose of this study is to use standardized and measurable ways to understand how gastroparesis therapy affects patient symptoms

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria

18 years of age or older
Fluent in English
Diagnosed with gastroparesis at Mayo
Sign an informed consent form prior to registry initiation

Exclusion Criteria

Under 18 years of age
Non-fluent in English
Institutionalized or incarcerated
Has a legal guardian
Circumstances that may affect participation with the registry:
- Inability to complete questionnaires
- Other conditions or circumstances that in the investigator’s opinion would limit the patient’s ability to participate or complete the registry.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location	Status
Rochester, Minn. Mayo Clinic principal investigator Yuri Saito Loftus, M.D.	Closed for enrollment

Mayo Clinic Location

Status

Rochester, Minn.

Mayo Clinic principal investigator

Yuri Saito Loftus, M.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Clinical Trials